Cereno Scientific’s CEO on novel therapies for rare diseases
BioStock met with Cereno Scientifics CEO Sten R. Sörensen at BioEurope. Cereno Scientific is developing novel therapies for rare diseases, with a mission to bring innovative treatments to enhance and extend the lives of patients with high unmet medical needs. In this interview, Sten shares insights on the company’s current projects, their objectives at BioEurope, and the future ahead.
Watch the interview with Sten R. Sörensen below:
